» Articles » PMID: 17302648

A Public Health Collaboration for the Surveillance of Autism Spectrum Disorders

Overview
Date 2007 Feb 17
PMID 17302648
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Autism spectrum disorders (ASDs) represent a range of behavioural phenotypes defined by impaired development in social interaction, communication, imagination, and range of interests or behaviours. The aetiology and epidemiology of these serious developmental disabilities (DDs) are poorly understood. Estimates of the population prevalence of ASDs have varied widely within the US and abroad, with increasing estimates in most of the recent studies. In an effort to improve our understanding of the prevalence, population characteristics and public health impact of these conditions, the Centers for Disease Control and Prevention has funded a multi-site surveillance network for ASDs and other DDs that consists of programmes known as the Autism and Developmental Disabilities Monitoring (ADDM) network which conducts surveillance activities and the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) which also conducts surveillance in addition to special research studies related to the ASDs. This collaboration will be referred to hereafter as the ADDM Network. The ADDM Network is implementing a multiple-source surveillance programme to determine population prevalence and characteristics of ASDs and other DDs. This paper describes the collaborative efforts and explains the methods in developing this coordinated public health surveillance network to provide an ongoing source of high-quality data on ASDs.

Citing Articles

Prevalence and Characteristics of Adolescents with Autism Spectrum Disorder in the New York-New Jersey Metropolitan Area.

Zahorodny W, Shenouda J, Sidwell K, Verile M, Cruz Alvarez C, Fusco A J Autism Dev Disord. 2023; .

PMID: 37642865 DOI: 10.1007/s10803-023-06058-8.


Oral Health Preventive Program in Patients with Autism Spectrum Disorder.

Carli E, Pasini M, Pardossi F, Capotosti I, Narzisi A, Lardani L Children (Basel). 2022; 9(4).

PMID: 35455579 PMC: 9031336. DOI: 10.3390/children9040535.


Patterns of Special Education Eligibility and Age of First Autism Spectrum Disorder (ASD) Identification Among US Children with ASD.

Esler A, Sample J, Hall-Lande J, Harris B, Rice C, Poynter J J Autism Dev Disord. 2022; 53(5):1739-1754.

PMID: 35212866 PMC: 9402793. DOI: 10.1007/s10803-022-05475-5.


Defining in Detail and Evaluating Reliability of DSM-5 Criteria for Autism Spectrum Disorder (ASD) Among Children.

Rice C, Carpenter L, Morrier M, Lord C, DiRienzo M, Boan A J Autism Dev Disord. 2022; 52(12):5308-5320.

PMID: 34981308 PMC: 9250939. DOI: 10.1007/s10803-021-05377-y.


The Role of Maternal Immune Activation in the Pathogenesis of Autism: A Review of the Evidence, Proposed Mechanisms and Implications for Treatment.

Zawadzka A, Cieslik M, Adamczyk A Int J Mol Sci. 2021; 22(21).

PMID: 34768946 PMC: 8584025. DOI: 10.3390/ijms222111516.